Tradewinds Universal
TRWDAbout the company
Tradewinds Universal develops, manufactures, and distributes nutrient-based edible insect foods under the Universal Protein brand. It focuses on the formulation, manufacturing, marketing, and distribution of UP Proteins nutritional products, which include protein bars, powders, drinks, cookies, and other health-conscious items, as well as shakes and various nutritional foods, snacks, and beverages. The company was incorporated in 2021 and is based in Las Vegas, Nevada.
Investment snapshot
Positive
1
BUY / PASS
Neutral / negative
2 / 13
NEUTRAL / FAIL
Median fair value
—
No comparable estimates
Models with upside
0 / 17
Positive margin of safety
Key risk
No clean pass — all 13 investors flag at least one valuation criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | Not ranked | PASS | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Margin of Safety | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-04-15 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-04-15 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-04-15 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-04-15 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-06-30 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-04-15 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-06-01–2026-11-01 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-04-15 Score computed: 2026-11-14 | TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-06-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-04-15 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-06-30 Latest source filing: 2026-08-19 Score computed: 2026-11-14 | TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2025-06-01–2026-11-01 Latest source filing: 2026-08-19 Score computed: 2026-11-14 |
Where It Passes
Where It Falls Short
- Valuation0% pass✓ 5✗ 23▾
No clean pass — all 13 investors flag at least one valuation criterion
Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio0.5x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value-204.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-204.0%, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xPrice / Book Value per Share0.5x✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)Valuation Reasonableness✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF Yield✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=0.5x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per Share✗Ackman<= 25Price vs. Trailing Low✗Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-849.33%; #6035/6340 (top 95.2%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.4057; #3249/6449 (top 50.4%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share1.27x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.3237; #3219/5247 (top 61.3%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date✗OshaughnessyTop 10% of eligible cross-section - Cash Flow0% pass✓ 1✗ 11▾
No clean pass — all 10 investors flag at least one cash flow criterion
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing✗LynchPositive and growingOperating Cash Flow$-0.1M✗PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=-18.73%, ROA=-290.52%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xP/E or FCF Yield✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap✗Ackman>= 4%Price / FCF per Share✗Ackman<= 25Positive Operating Cash Flow frequency0/3 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization✗OshaughnessyTop 10% of eligible cross-section - Growth0% pass✓ 1✗ 12▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction$-0.02 (2023) -> $-0.01 (2025)✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency0/3 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-2.0%✗Ackman>= 5%Positive EPS Growth Frequency1/2 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency0% pass✗ 11▾
All 8 investors flag TRWD's efficiency
Current Ratio0.87✗Graham>= 2.0ROIC (3-5 yr avg)✗Buffett> 10%ROIC - WACC✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)✗Greenblatt> 25%Current Ratio Change YoY✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY5.45x -> 0.43x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities0.87✗Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)✗SleepROIC > 12% in a majority of years - Profitability6% pass✓ 5✗ 30▾
15 of 16 flag TRWD's profitability — Graham, Buffett, Lynch +12 more
Positive EPS (10 years)0/4 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)0/4 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-260.5%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-2093.4%✗Lynch> 15%EBIT / Enterprise Value-204.0%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=-204.0%, ROC=None✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets-290.52%✗PiotroskiROA > 0ROA Change YoY-367.32% -> -290.52% (delta: +76.80%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=-18.73%, ROA=-290.52%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY87.4% -> 100.0%✓PiotroskiImproved YoYPre-Tax Income / Revenue-2624.2%✗Dreman>= 8%Net Income / Shareholders' Equity-2093.4%✗Dreman> 12%Margin of SafetyP/B=0.5x✓PabraiP/B < 1.5 or P/E < 15Return on Equity-260.5% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency0/3 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity-2093.4%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-849.33%; #6035/6340 (top 95.2%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+53.22%; #598/3702 (top 16.2%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity-2093.42%; #5195/5226 (top 99.4%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-1.0168; #5277/5884 (top 89.7%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts7% pass✓ 1✗ 13▾
Split decision: 13 FAIL · 2 NEUTRAL · 1 PASS
Overall verdict✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 4)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (0/6)✗MarksFAIL (1/5)✗AckmanFAIL (1/9)✗TempletonFAIL (3/8)✗SleepFAIL (0/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (0/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Debt & Leverage33% pass✓ 6✗ 9▾
8 of 12 flag TRWD's debt & leverage — Graham, Buffett, Lynch +5 more
Debt Levels0.35✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest Coverage✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.35✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities0.87✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.35✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xInterest Coverage & Debt/EBITDA✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.35✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.3526; #2141/4210 (top 50.9%)✗AsnessTop 30% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 32.7% of shares last year.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-06-30 2025-07-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, revenue, net income, gross profit, pre tax income. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
|
|---|---|---|---|---|---|---|---|
| Market Cap | $454.3Kcurrent | -- | -- | $4.3Mest. | $19.3Mest. | -- | -- |
| Revenue | $147.1K↑70% | $25.0K↑25% | $21.8K↑68% | $133.2K↓22% | $171.6K↑18% | $145.1K | -- |
| Operating Income | -- | -- | -- | -- | -- | -- | -- |
| Net Income | -$3.9M↓4958% | -$2.9M↓11302% | -$125.3K↓11172% | -$892.9K↓671% | -$115.7K↑36% | -$182.2K | -- |
| EPS (Diluted) | -- | $-0.02 | $0.00 | $-0.01 | $-0.01↑50% | $-0.02 | -- |
| Gross Margin | 100.0%↑12% | 100.0% | 100.0% | 100.0%↑14% | 87.4%↓4% | 91.0% | — |
| Operating Margin | — | — | — | — | — | — | — |
| ROE | -2093.4%↓730% | — | — | -290.5%↑21% | -367.3%↓197% | -123.7% | — |
| Total Debt | $65.0K | $65.0K | $25.0K | -- | -- | -- | -- |
| Shareholders' Equity | $184.3K↑509% | $184.3K↑509% | $232.0K↑663% | $307.3K↑875% | $31.5K↓79% | $147.3K↑90% | $77.4K |
| Current Ratio | 0.87 | 0.87 | 1.49 | — | — | — | — |
| Debt / Equity | 0.35 | 0.35 | 0.11 | — | — | — | — |
| Operating Cash Flow | -$198.7K↓560% | -$65.0K↓5373% | -$76.0K↓6738% | -$57.6K↓106% | -$28.0K↑50% | -$55.6K | -- |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Food Products
TRWD vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mondelez International, Inc.MDLZ | $85.5B | $67.54 | $38.5B | $2.5B | 9.5% | 0.72 | 9.2% | 0.59 | 2/9 | 3/9 | 3/7 | 0/3 | F-Score 6 | 4/11 |
| Archer-Daniels-Midland CoADM | $34.7B | $72.90 | $80.3B | $1.1B | 4.7% | 0.33 | — | 1.37 | 5/9 | 2/9 | 1/7 | 0/3 | F-Score 5 | 5/11 |
| TYSON FOODS, INC.TSN | $20.7B | $58.82 | $54.4B | $474.0M | 2.6% | 0.49 | 2.0% | 1.55 | 3/9 | 2/9 | 0/7 | 0/3 | F-Score 5 | 3/11 |
| GENERAL MILLS INCGIS | $18.4B | $34.32 | $18.4B | $87.6M | -1.2% | 1.83 | 4.8% | 0.68 | 3/9 | 4/9 | 0/7 | 1/3 | F-Score 5 | 2/11 |
| HORMEL FOODS CORP /DE/HRL | $12.2B | $22.09 | $12.1B | $478.2M | 6.1% | 0.36 | 5.9% | 2.47 | 3/9 | 3/9 | 2/7 | 0/3 | F-Score 5 | 4/11 |
| Lamb Weston Holdings, Inc.LW | $7.7B | $56.06 | $6.6B | $290.0M | 15.9% | 2.01 | 8.9% | 1.42 | 2/9 | 4/9 | 0/7 | 0/3 | F-Score 7 | 3/11 |
| SMITHFIELD FOODS INCSFD | $7.6B | $19.19 | $15.5B | $987.0M | 14.5% | 0.29 | 8.3% | 2.97 | 6/9 | 3/9 | 3/7 | 3/3 | F-Score 6 | 8/11 |
| CONAGRA BRANDS INC.CAG | $7.0B | $14.73 | $11.3B | $1.9B | -30.1% | 1.14 | -14.4% | 0.90 | 3/9 | 0/9 | 1/7 | 0/3 | F-Score 4 | 4/11 |